Boehringer Ingelheim Pharmaceuticals, Inc. recalls Catapres .2 (clonidine hydrochloride, USP) 0.2mg, 100-count bottles, Rx only, Dist. by: Boehringer Ingelheim Pharmaceuti
Recalled November 7, 2018 · FDA recall D-0128-2019 · Boehringer Ingelheim Pharmaceuticals
Hazard
Failed Dissolution Specifications: OOS resultsduring routine stability testing · FDA Class II
Units
1,380 100-count bottles
Sold at
Distributed nationwide in the USA and Puerto Rico
Description
Failed Dissolution Specifications: OOS resultsduring routine stability testing
Product
Catapres .2 (clonidine hydrochloride, USP) 0.2mg, 100-count bottles, Rx only, Dist. by: Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877 USA. Made in Germany. NDC 0597-0007-01
Manufacturer(s)
Boehringer Ingelheim Pharmaceuticals, Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →